Global Hadron Therapy Market: Overview
A kind of therapy that uses ionizing radiations for the cancer treatment is known as hadron therapy. The difference between the other radiation therapies and hadron therapy is the radiation beams consist of particles that are charged that is the protons and other ions. The uniqueness of this therapy is radiobiological and the physical properties of the particles permit them to penetrate into the tissues with maximum transfer of energy and less diffusion within a certain area. When compared with other radiation therapies hadron therapy has an advantage, that is, it causes minimum damage to the tissues that are healthy which are surrounding the cancerous part. Thus it is very helpful to the pediatric patients and in tumors that are situated in vital parts of the body.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Global Hadron Therapy Market: Segmentation
The global hadron therapy is fragmented into its application, type of particle radiation, and end user. On the basis of application, the global market is segregated into pediatric cancer, prostate cancer, liver cancer, head & neck cancer, bone & soft tissue cancer, lung cancer, an eye cancer. Depending on the type of particle radiation, the market is divided into the electron beam, neutron beam, alpha particle beam, proton beam, carbon ion beam, and beta particle beam. The end-users segment is categorized into government universities, hospitals, and research institutions.
Global Hadron Therapy Market: Growth Factors
The key factor that is contributing to the hadron market growth is the increase in a number of people that are being diagnosed with cancer. The factor that has caught the attention of the patients and the health professionals is the technological advancement that is made which helps in minimizing the adverse effects and healthy tissues are transferred with fewer radiations thus being safe. There are certain factors that may affect the Hadron market growth negatively which include the fact that there are very few number of therapy providers, the installation of the equipment requires a large area, the treatment cost is comparatively high, lack of skilled clinicians, and space for optimization and refinement of technology.
Global Hadron Therapy Market: Regional Analysis
The geographical segmentation of the global hadron therapy market is diversified into North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific, and the Middle East and Africa. The region that is dominating the hadron therapy market is the North America. It is currently leading the market and is followed by Europe. The significant factor that attributes to this dominance is that majority of the doctors and physicians are present in the regions of North America and Europe. In Asia Pacific region countries such as Korea and Japan are now providing facilities of therapy. China and India are also giving the facilities of therapy as few treatment providers have now emerged in this region.
Global Hadron Therapy Market: Competitive Players
The key market players that are involved in the hadron therapy market include Koninklijke Philips N.V., Optivus Proton Therapy, Inc., Hitachi, Ltd., Sumitomo Corporation, Mitsubishi Electric Corporation, Elekta, IBA Worldwide, Advanced Oncotherapy, Varian Medical Systems, Inc., Mevion Medical Systems, ProNova Solutions, Llc., and ProTom International.
Global Hadron Therapy Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets